Nomogram for predicting pathologically complete response after neoadjuvant chemoradiotherapy for oesophageal cancer. Issue 3 (June 2015)
- Record Type:
- Journal Article
- Title:
- Nomogram for predicting pathologically complete response after neoadjuvant chemoradiotherapy for oesophageal cancer. Issue 3 (June 2015)
- Main Title:
- Nomogram for predicting pathologically complete response after neoadjuvant chemoradiotherapy for oesophageal cancer
- Authors:
- Toxopeus, Eelke Lucie Anne
Nieboer, Daan
Shapiro, Joel
Biermann, Katharina
van der Gaast, Ate
van Rij, Carolien M.
Steyerberg, Ewout Willem
van Lanschot, Joseph Jan Baptiste
Wijnhoven, Bas Peter Louis - Abstract:
- <abstract xml:lang="en" abstract-type="author" id="ab005"> <title id="st005">Abstract</title> <sec> <title id="st010">Background</title> <p id="sp0005">A pathologically complete response (pCR) to neoadjuvant chemoradiotherapy (nCRT) is seen in 30% of the patients with oesophageal cancer. The aim is to identify patient and tumour characteristics associated with a pCR and to develop a nomogram for the prediction of pCR.</p> </sec> <sec> <title id="st015">Patients and methods</title> <p id="sp0010">Patients who underwent nCRT followed by surgery were identified and response to nCRT was assessed according to a modified Mandard classification in the resection specimen. A model was developed with age, gender, histology and location of the tumour, differentiation grade, alcohol use, smoking, percentage weight loss, Charlson Comorbidity Index (CCI), cT-stage and cN-stage as potential predictors for pCR. Probability of pCR was studied via logistic regression. Performance of the prediction nomogram was quantified using the concordance statistic (<italic>c</italic>-statistic) and corrected for optimism.</p> </sec> <sec> <title id="st020">Results</title> <p id="sp0015">A total of 381 patients were included. After surgery, 27.6% of the tumours showed a pCR. Female sex, squamous cell histology, poor differentiation grade, and low cT-stage were predictive for a pCR with a <italic>c</italic>-statistic of 0.64 (corrected for optimism).</p> </sec> <sec> <title id="st025">Conclusion</title> <p<abstract xml:lang="en" abstract-type="author" id="ab005"> <title id="st005">Abstract</title> <sec> <title id="st010">Background</title> <p id="sp0005">A pathologically complete response (pCR) to neoadjuvant chemoradiotherapy (nCRT) is seen in 30% of the patients with oesophageal cancer. The aim is to identify patient and tumour characteristics associated with a pCR and to develop a nomogram for the prediction of pCR.</p> </sec> <sec> <title id="st015">Patients and methods</title> <p id="sp0010">Patients who underwent nCRT followed by surgery were identified and response to nCRT was assessed according to a modified Mandard classification in the resection specimen. A model was developed with age, gender, histology and location of the tumour, differentiation grade, alcohol use, smoking, percentage weight loss, Charlson Comorbidity Index (CCI), cT-stage and cN-stage as potential predictors for pCR. Probability of pCR was studied via logistic regression. Performance of the prediction nomogram was quantified using the concordance statistic (<italic>c</italic>-statistic) and corrected for optimism.</p> </sec> <sec> <title id="st020">Results</title> <p id="sp0015">A total of 381 patients were included. After surgery, 27.6% of the tumours showed a pCR. Female sex, squamous cell histology, poor differentiation grade, and low cT-stage were predictive for a pCR with a <italic>c</italic>-statistic of 0.64 (corrected for optimism).</p> </sec> <sec> <title id="st025">Conclusion</title> <p id="sp0020">A nomogram for the prediction of pathologically complete response after neoadjuvant chemoradiotherapy was developed, with a reasonable predictive power. This nomogram needs external validation before it can be used for individualised clinical decision-making.</p> </sec> </abstract> … (more)
- Is Part Of:
- Radiotherapy and oncology. Volume 115:Issue 3(2015:Jun.)
- Journal:
- Radiotherapy and oncology
- Issue:
- Volume 115:Issue 3(2015:Jun.)
- Issue Display:
- Volume 115, Issue 3 (2015)
- Year:
- 2015
- Volume:
- 115
- Issue:
- 3
- Issue Sort Value:
- 2015-0115-0003-0000
- Page Start:
- 392
- Page End:
- 398
- Publication Date:
- 2015-06
- Subjects:
- Oncology -- Periodicals
Radiotherapy -- Periodicals
Tumors -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- radiotherapy -- Periodicals
Radiotherapy -- Periodicals
Radiothérapie -- Périodiques
Cancérologie -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9940642 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01678140 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01678140 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01678140 ↗
http://www.estro.org/ ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/radiotherapy-and-oncology/ ↗ - DOI:
- 10.1016/j.radonc.2015.04.028 ↗
- Languages:
- English
- ISSNs:
- 0167-8140
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7240.790000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3548.xml